Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
Moreira (Sales), Rosario Jorge (Mar ket ing); Man -<br />
u fac ture: Miguel Caldas (Lo gis tics); Mar ket Re -<br />
search: Rosario Jorge; Re search & De vel op ment:<br />
Rita Munes; Gen eral Con tact: Carlos Simoes<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
Phar ma ceu ti cal Sales: US$ 24-26 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 65-70%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 70-75%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
85-90%<br />
Prin ci pal Prod ucts:<br />
VOLTAREN EMULGEL (antirheumatic top i cal)<br />
VIBROCIL (na sal prep a ra tion top i cal)<br />
MEBOCAINA (throat prep a ra tion)<br />
FENISTIL (antipruritic)<br />
PURSENNIDE (lax a tive)<br />
Ther a peu tic Range:<br />
anti rheu ma tics top i cal 38%<br />
na sal prep a ra tions 13%<br />
throat prep a ra tions 10%<br />
antipruritics 6%<br />
antivaricosis/antihemorrhoidal prep a ra tions<br />
6%<br />
Lead ing Dose Forms:<br />
gels/sols 48%<br />
liq uids 20%<br />
spe cial solid forms 13%<br />
coated tab lets 5%<br />
tab lets 4%<br />
SANDOZ<br />
Full Name: Sandoz Farmaceutica Lda.<br />
Street Ad dress: Alameda da Beloura, Edificio EE<br />
1, 2do andar - Escritorio 15, Quinta da Beloura,<br />
P-2710-444 Sintra<br />
Tel: +351 21 924 19 11<br />
Fax: +351 21 924 98 04<br />
Phar ma ceu ti cal Sales: US$ 28-30 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 40-45%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 65-70%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
95-100%<br />
Prin ci pal Prod ucts:<br />
SINVASTATIN MG SDZ (cho les terol/triglyceride<br />
reg u lat ing prep a ra tion)<br />
OMEPRAZOL MG SDZ (antiulcerant)<br />
CAL CIUM D SANDOZ (cal cium prod uct)<br />
AMOX.A.CLAV.MG SDZ (pen i cil lin broad spec -<br />
trum)<br />
SERTRALINA MG SDZ (an ti de pres sant)<br />
Ther a peu tic Range:<br />
lipid-reg u lat ing/antiatheroma prep a ra tions<br />
18%<br />
ant ac ids/antiflatulents/antiulcerants 18%<br />
antibacterials sys temic 12%<br />
min eral sup ple ments 10%<br />
renin-an gio ten sin sys tem agents 9%<br />
Lead ing Dose Forms:<br />
coated tab lets 46%<br />
tab lets 28%<br />
cap sules 21%<br />
gels/sols 2%<br />
pow ders/gran ules 1%<br />
PUERTO RICO<br />
CIBA VI SION<br />
Full Name: CIBA Vi sion Puerto Rico, Inc.<br />
Postal Ad dress: PO Box 1360, Cidra, 00739<br />
Street Ad dress: El Jibaro In dus trial Park, Lots<br />
No. 1 & 2, Cidra, 00739<br />
Tel: +1 787 434-7200<br />
Fax: +1 787 739-1440<br />
Sub sid iary of: Novartis, Swit zer land (100%)<br />
GERBER<br />
Full Name: Gerber Prod ucts Com pany of Puerto<br />
Rico, Inc.<br />
Postal Ad dress: PO Box 1769, Carolina,<br />
00984-1769<br />
Street Ad dress: URB In dus trial Julio N. Matos,<br />
Carr 887, K.M.O., HM7, Lote 26, Carolina, 00987<br />
Tel: +1 787 769-7745<br />
Fax: +1 787 762-1945<br />
Home Page: www.novartisnutrition.com<br />
ROMANIA<br />
HEXAL<br />
Full Name: Hexal Ro ma nia s.r.l.<br />
Street Ad dress: Cal. Plevnei, No. 141, Bl. 3, Apt.<br />
33, Sec tor 6, 74325 Bu cha rest<br />
Tel: +40 21 315 15 00<br />
Fax: +40 21 316 37 03<br />
De scrip tion: Dis trib u tor, pro moter,<br />
sales/detailer. Es tab lished 1998.<br />
Con tacts (Pharm): Chair man: Dr Dinu<br />
Stanculeanu<br />
Phar ma ceu ti cal Sales: US$ 30-35 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 70-75%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 80-85%<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 199
Change language